Literature DB >> 19773603

[New incidence and mortality data. 2003-2005].

Emanuele Crocetti, Carlotta Buzzoni.   

Abstract

This is an update of incidence and mortality cancer data provided by the Italian Network of Cancer Registry (AIRTUM) relative to the period 2003-2005.AIRTUM is a network of general and specialized population-based cancer registries that covers about 1/3 of the Italian resident population (www.registri-tumori.it). Incidence and mortality data for the period 2003-2005 are based on 20 Registries. The five most frequently diagnosed cancers were: - prostate (18.5%), non melanoma skin (15.8%), lung (13.1%), colorectal (12.0%), bladder (5.7%) among males; - breast (24.9%), non melanoma skin (15.1%), colorectal (11.9%), lung (5.0%) and stomach (4.1%) among females. In the same period the most frequent causes of cancer death were: - cancer of the lung (27.6%), colorectal (10.7%), prostate (8.5%), stomach (7.3%) and liver (6.1%) among males; - breast cancer (16.3%), colorectal (11.9%), lung (10.3%), stomach (7.2%) and pancreas (6.5%) among females. According to the age-specific incidence rates one man and one woman every two will receive a cancer diagnosis during his/hers life (from birth to the age of 84 years). From 1993-1995 to 2003-2005, overall crude cancer incidence rate (males and females together) increased from 555.4 to 654.8 x 100,000. Standardization showed that 63% of this increase was due to ageing of the population. Moreover, most of the residual increase was among those cancer sites (breast, prostate, colorectal, thyroid and melanoma) for which early detection may have played a relevant role in anticipating (and therefore increasing) the number of diagnoses. Due to population ageing also overall cancer mortality did not show any decrease when crude rates were compared. On the contrary, standardized mortality rates (all cancers together) showed a strong decrease (311.4 vs. 266.5 x 100.000). The risk of receiving a diagnosis or dying because of cancer is still lower in residents in the regions of the South of Italy than in those of Central and Northern Italy, but they are becoming more and more similar. In Italy cancer incidence and mortality rates are similar to those in northern European countries and in USA among males, but they are still lower for women.

Entities:  

Mesh:

Year:  2009        PMID: 19773603

Source DB:  PubMed          Journal:  Epidemiol Prev        ISSN: 1120-9763            Impact factor:   1.901


  8 in total

1.  Relative and disease-free survival for breast cancer in relation to subtype: a population-based study.

Authors:  Pamela Minicozzi; Francesca Bella; Angela Toss; Adriano Giacomin; Mario Fusco; Maurizio Zarcone; Rosario Tumino; Fabio Falcini; Rosaria Cesaraccio; Giuseppa Candela; Francesco La Rosa; Massimo Federico; Milena Sant
Journal:  J Cancer Res Clin Oncol       Date:  2013-07-28       Impact factor: 4.553

2.  Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients.

Authors:  Francesca Bella; Pamela Minicozzi; Adriano Giacomin; Emanuele Crocetti; Massimo Federico; Maurizio Ponz de Leon; Mario Fusco; Rosario Tumino; Lucia Mangone; Orietta Giuliani; Mario Budroni; Milena Sant
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-30       Impact factor: 4.553

3.  Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial.

Authors:  Daniele Regge; Gabriella Iussich; Carlo Senore; Loredana Correale; Cesare Hassan; Alberto Bert; Stefania Montemezzi; Nereo Segnan
Journal:  Trials       Date:  2014-03-28       Impact factor: 2.279

4.  Screening to Identify Commonly Used Chinese Herbs That Affect ERBB2 and ESR1 Gene Expression Using the Human Breast Cancer MCF-7 Cell Line.

Authors:  Jen-Hwey Chiu; Chun-Ju Chang; Jing-Chong Wu; Hui-Ju Liu; Che-Sheng Wen; Chung-Hua Hsu; Jiun-Liang Chen; Ling-Ming Tseng; Wei-Shone Chen; Yi-Ming Shyr
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-27       Impact factor: 2.629

5.  Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.

Authors:  Jen-Hwey Chiu; Che-Sheng Wen; Jir-You Wang; Chih-Yi Hsu; Yi-Fang Tsai; Shih-Chieh Hung; Ling-Ming Tseng; Yi-Ming Shyr
Journal:  J Transl Med       Date:  2017-05-04       Impact factor: 5.531

6.  Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study).

Authors:  Lapo Sali; Grazia Grazzini; Francesca Carozzi; Guido Castiglione; Massimo Falchini; Beatrice Mallardi; Paola Mantellini; Leonardo Ventura; Daniele Regge; Marco Zappa; Mario Mascalchi; Stefano Milani
Journal:  Trials       Date:  2013-03-15       Impact factor: 2.279

7.  Cancer prevalence in the city of Naples: Contribution of the GP database analyses to the cancer registries network.

Authors:  Claudia Pizzi; Grazia Arpino; Giuseppe Acampora; Nadia Aiello; Augusto DE Rosa; Immacolata Diaferia; Alessandro DI Nunzio; Giuseppe Fragna; Amedeo Franco; Maria Russo; Fulvia Sansone; Carmela Scarpati; Antonio Spinuso; Giovanni Arpino; Amalia Luce; Giuseppina Tommasielli; Michele Caraglia; Sabino DE Placido
Journal:  Mol Clin Oncol       Date:  2013-04-04

8.  Socioeconomic deprivation worsens the outcomes of Italian women with hormone receptor-positive breast cancer and decreases the possibility of receiving standard care.

Authors:  Francesca Di Salvo; Nicola Caranci; Teresa Spadea; Nicolas Zengarini; Pamela Minicozzi; Hade Amash; Mario Fusco; Fabrizio Stracci; Fabio Falcini; Claudia Cirilli; Giuseppina Candela; Rosanna Cusimano; Rosario Tumino; Milena Sant
Journal:  Oncotarget       Date:  2017-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.